Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 15:12:475.
doi: 10.1186/1471-2105-12-475.

Performance analysis of novel methods for detecting epistasis

Affiliations

Performance analysis of novel methods for detecting epistasis

Junliang Shang et al. BMC Bioinformatics. .

Abstract

Background: Epistasis is recognized fundamentally important for understanding the mechanism of disease-causing genetic variation. Though many novel methods for detecting epistasis have been proposed, few studies focus on their comparison. Undertaking a comprehensive comparison study is an urgent task and a pathway of the methods to real applications.

Results: This paper aims at a comparison study of epistasis detection methods through applying related software packages on datasets. For this purpose, we categorize methods according to their search strategies, and select five representative methods (TEAM, BOOST, SNPRuler, AntEpiSeeker and epiMODE) originating from different underlying techniques for comparison. The methods are tested on simulated datasets with different size, various epistasis models, and with/without noise. The types of noise include missing data, genotyping error and phenocopy. Performance is evaluated by detection power (three forms are introduced), robustness, sensitivity and computational complexity.

Conclusions: None of selected methods is perfect in all scenarios and each has its own merits and limitations. In terms of detection power, AntEpiSeeker performs best on detecting epistasis displaying marginal effects (eME) and BOOST performs best on identifying epistasis displaying no marginal effects (eNME). In terms of robustness, AntEpiSeeker is robust to all types of noise on eME models, BOOST is robust to genotyping error and phenocopy on eNME models, and SNPRuler is robust to phenocopy on eME models and missing data on eNME models. In terms of sensitivity, AntEpiSeeker is the winner on eME models and both SNPRuler and BOOST perform well on eNME models. In terms of computational complexity, BOOST is the fastest among the methods. In terms of overall performance, AntEpiSeeker and BOOST are recommended as the efficient and effective methods. This comparison study may provide guidelines for applying the methods and further clues for epistasis detection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Classification of the methods that detect epistasis. All methods can be classified into three categories according to their search strategies, i.e., exhaustive search, stochastic search, and heuristic search. Methods with bold names are described and evaluated in detail. Detailed information of these methods is provided in supplementary table S1 in additional file 1.
Figure 2
Figure 2
Detection power of the methods on 100-SNP non-noise datasets.
Figure 3
Figure 3
Detection power of the methods on 10000-SNP non-noise datasets.
Figure 4
Figure 4
Detection power of the methods on 100-SNP noise datasets with 5% missing data.
Figure 5
Figure 5
Detection power of the methods on 100-SNP noise datasets with 5% genotyping error.
Figure 6
Figure 6
Detection power of the methods on 100-SNP noise datasets with 20% phenocopy.
Figure 7
Figure 7
Sensitivity of the methods at 0.01 FPR.
Figure 8
Figure 8
Left-side ROC curves of the methods on datasets.

Similar articles

Cited by

References

    1. Amato R, Pinelli M, D'Andrea D, Miele G, Nicodemi M, Raiconi G, Cocozza S. A novel approach to simulate gene-environment interactions in complex diseases. BMC Bioinformatics. 2010;11:8. doi: 10.1186/1471-2105-11-8. - DOI - PMC - PubMed
    1. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet. 2001;2(2):91–99. - PubMed
    1. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516–1517. doi: 10.1126/science.273.5281.1516. - DOI - PubMed
    1. Maher B. Personal genomes: The case of the missing heritability. Nature. 2008;456(7218):18–21. doi: 10.1038/456018a. - DOI - PubMed
    1. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11(20):2463–2468. doi: 10.1093/hmg/11.20.2463. - DOI - PubMed

Publication types

LinkOut - more resources